This list contains only the countries for which job offers have been published in the selected language (e.g., in the French version, only job offers written in French are displayed, and in the English version, only those in English).
A leadership role focused on establishing AI-based drug discovery collaborations and partnerships through Internal Medicines’ AI-Driven Cardiometabolic Drug Discovery Institute. This role will partner with IM leadership to implement a strategic vision of building a collaborative ecosystem where AI and bench scientists work side-by-side to co-create value for patients. This role will actively engage with entrepreneurs, biotech companies and academic organizations to identify compelling emerging science opportunities at the interface of AI and cardiometabolic disease drug discovery. This leader will also be responsible for leading the scientific, logistical and business aspects of complex partnerships and presenting regular updates to senior leadership on progress and milestone achievements.
Job Responsibility:
Partner with IM leadership to accelerate innovation leveraging entrepreneurial and scientific advice, funding, and space to derisk and develop tangible concepts in CMD-specific drug discovery
Act as an “entrepreneur in residence” focused on identifying, implementing and managing high profile collaborative or incubator partnerships that advance the integration of AI-driven strategies into the discovery and development of novel cardiometabolic drug candidates
Represent IM to external collaboration partners and serve as a networker who forges strong relationships with academic, biopharma and entrepreneur stakeholders to attract ideas and catalyze new ways of thinking about the application of AI to cardiometabolic drug discovery problems
Establish appropriate oversight and metrics for portfolio of collaborative projects to measure success and demonstrate value generation
Function as an interface between the IM, Business Development (BD), Legal, Discovery Network and other supporting lines to help navigate collaborations and maximize return on investments in external science
Actively manage collaboration and partnership risks, devising and implementing appropriate mitigation strategies
Communicate collaboration status to senior leaders and act as a champion for the asset to ensure appropriate resources (budget and FTEs) are secured and deployed to facilitate delivery of the collaboration plan
Requirements:
PhD or MD with at least 10+ years’ experience including relevant Internal Medicine-based scientific discipline(s) and a broad understanding of cardiometabolic disease biology
Contemporary knowledge of the application of AI to solve drug discovery problems
Strong track record of business development experience with demonstrated ability to implement and delivering results from complex alliances amongst industry, venture, biotech and academic stakeholders
Experience leveraging venture investment strategies to incubate new companies and joint ventures
Experience developing collaborative research plans with milestone-based incentives
Ability to effectively facilitate complex, strategic conversations
Strong leadership and presentation and skills
Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact
Nice to have:
Track record of successfully working effectively with multidisciplinary teams in collaborative environments
Entrepreneurial thinking coupled with strong organizational skills
Demonstrated success in negotiating the environment of a highly matrix-based organization
What we offer:
401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution
paid vacation
holiday and personal days
paid caregiver/parental and medical leave
health benefits to include medical, prescription drug, dental and vision coverage
participation in Pfizer’s Global Performance Plan with a bonus target of 25.0% of the base salary
eligibility to participate in our share based long term incentive program